Literature DB >> 35396463

New tool to investigate spike-specific CD4+ T cells.

Alexandra Flemming1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35396463      PMCID: PMC8990497          DOI: 10.1038/s41577-022-00723-2

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


× No keyword cloud information.
Both CD8+ and CD4+ T cells against the SARS-CoV-2 spike protein have been associated with reduced severity of COVID-19, indicating a role for T cells in limiting viral pathogenesis. In addition, spike-specific CD4+ T follicular helper (TFH) cells support B cell maturation and neutralizing antibody production. Using a novel peptide–MHC tetramer to track human spike-specific CD4+ T cells, Wragg et al. now demonstrate that SARS-CoV-2 infection or vaccination induces robust CXCR5– T memory and circulating TFH cell responses, which are efficiently recalled upon antigen re-exposure and may contribute to long-term protection against SARS-CoV-2.
  1 in total

1.  Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory.

Authors:  Kathleen M Wragg; Wen Shi Lee; Marios Koutsakos; Hyon-Xhi Tan; Thakshila Amarasena; Arnold Reynaldi; Grace Gare; Penny Konstandopoulos; Kirsty R Field; Robyn Esterbauer; Helen E Kent; Miles P Davenport; Adam K Wheatley; Stephen J Kent; Jennifer A Juno
Journal:  Nat Immunol       Date:  2022-03-21       Impact factor: 31.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.